Crescent Capital BDC (CCAP) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
1 Apr, 2026Executive summary
Annual Meeting scheduled for May 15, 2026, will be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and annual report before voting.
Voting matters and shareholder proposals
Election of two Class II Directors to serve until the 2029 Annual Meeting.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
Provision to transact other business that may arise during the meeting or any adjournment.
Board of directors and corporate governance
Nominees for Class II Director positions are Susan Yun Lee and Michael S. Segal, both recommended by the Board.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Crescent Capital BDC
- Net investment income fell to $0.36 per share as NAV declined and risk management remained a focus.CCAP
Q2 2026 - Directors were elected for three-year terms and the auditor was ratified with no shareholder questions.CCAP
AGM 2026 - Net investment income and NAV per share declined, with fee reductions and special dividends announced.CCAP
Q1 2026 - Virtual meeting to elect directors and ratify E&Y as auditor, with strong governance oversight.CCAP
Proxy filing - Q4 net investment income covered the dividend, with NAV at $19.10 and a strong, diversified portfolio.CCAP
Q4 2025 - Net investment income per share was $0.46 for Q3 2025, with NAV per share at $19.28.CCAP
Q3 2025 - Q3 net investment income rose to $0.64 per share, with strong liquidity and low non-accruals.CCAP
Q3 2024 - Q2 2024 NII reached $0.59/share, NAV hit $20.30, with strong liquidity and low nonaccruals.CCAP
Q2 2024 - Q4 2024 featured stable NAV, strong liquidity, robust dividends, and a diversified portfolio.CCAP
Q4 2024